Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide.
Flawless balance sheet and slightly overvalued.
Share Price & News
How has Allied Healthcare Products's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AHPI's share price has been volatile over the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: AHPI exceeded the US Medical Equipment industry which returned 16.8% over the past year.
Return vs Market: AHPI exceeded the US Market which returned 15.4% over the past year.
Price Volatility Vs. Market
How volatile is Allied Healthcare Products's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StNeed To Know: Allied Healthcare Products, Inc. (NASDAQ:AHPI) Insiders Have Been Selling Shares
2 months ago | Simply Wall StDon't Ignore The Fact That This Insider Just Sold Some Shares In Allied Healthcare Products, Inc. (NASDAQ:AHPI)
3 months ago | Simply Wall StA Look At The Fair Value Of Allied Healthcare Products, Inc. (NASDAQ:AHPI)
Is Allied Healthcare Products undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AHPI ($10.43) is trading below our estimate of fair value ($71.31)
Significantly Below Fair Value: AHPI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AHPI is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: AHPI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AHPI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AHPI is overvalued based on its PB Ratio (4.4x) compared to the US Medical Equipment industry average (4.2x).
How is Allied Healthcare Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allied Healthcare Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Allied Healthcare Products's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Explore growth companies in the Healthcare industry.
How has Allied Healthcare Products performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AHPI is currently unprofitable.
Growing Profit Margin: AHPI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AHPI is unprofitable, and losses have increased over the past 5 years at a rate of 3.9% per year.
Accelerating Growth: Unable to compare AHPI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AHPI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.2%).
Return on Equity
High ROE: AHPI has a negative Return on Equity (-31.33%), as it is currently unprofitable.
How is Allied Healthcare Products's financial position?
Financial Position Analysis
Short Term Liabilities: AHPI's short term assets ($12.0M) exceed its short term liabilities ($6.6M).
Long Term Liabilities: AHPI has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: AHPI is debt free.
Reducing Debt: AHPI had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AHPI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AHPI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 26.8% per year.
What is Allied Healthcare Products's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AHPI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AHPI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AHPI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AHPI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AHPI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Earl Refsland (77 yo)
Mr. Earl R. Refsland has been the President and Chief Executive Officer at Allied Healthcare Products Inc. since September 1999. From May 1995 to March 1998, Mr. Refsland served as the President and Chief ...
CEO Compensation Analysis
Compensation vs Market: Earl's total compensation ($USD502.49K) is about average for companies of similar size in the US market ($USD606.98K).
Compensation vs Earnings: Earl's compensation has been consistent with company performance over the past year.
|CEO, President & Director||20.92yrs||US$502.49k||4.65% |
|Independent Chairman||no data||US$25.77k||29.02% |
|Independent Director||13.83yrs||US$26.47k||0.025% |
|Independent Director||16.5yrs||US$27.47k||0.0062% |
|Independent Director||0.67yr||no data||no data|
Experienced Board: AHPI's board of directors are seasoned and experienced ( 15.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AHPI insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Allied Healthcare Products, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Allied Healthcare Products, Inc.
- Ticker: AHPI
- Exchange: NasdaqCM
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$41.861m
- Shares outstanding: 4.01m
- Website: https://www.alliedhpi.com
Number of Employees
- Allied Healthcare Products, Inc.
- 1720 Sublette Avenue
- St. Louis
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|AHPI||NasdaqCM (Nasdaq Capital Market)||Yes||Common Stock||US||USD||Jan 1992|
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respirat ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/07 01:36|
|End of Day Share Price||2020/08/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.